Continuation Versus Discontinuation of Sodium‐Glucose Cotransporter‐2 Inhibitors and Cardiorenal Outcomes Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Cohort Study With a Target Trial Emulation Framework

ABSTRACT Clinical guidelines recommend continuation of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) treatment when renal function deteriorates among patients with type 2 diabetes. However, the recommendation is not currently supported by research specifically designed to compare continuation ve...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaa‐Hui Dong, Chia‐Hsuin Chang, Li‐Chiu Wu, Sengwee Toh
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Clinical and Translational Science
Subjects:
Online Access:https://doi.org/10.1111/cts.70319
Tags: Add Tag
No Tags, Be the first to tag this record!